# Clinical Trial to Assess the Improvement of Fatigue, Sleep Problems, Anxiety / Depression, Neurovegetatives Alterations and Quality of Life After the Administration of ImmunoVita® in Chronic Fatigue Syndrome Patients

> **NCT04301609** · NA · COMPLETED · sponsor: **Vitae Health Innovation** · enrollment: 67 (actual)

## Conditions studied

- Chronic Fatigue Syndrome
- Myalgic Encephalomyelitis

## Interventions

- **DIETARY_SUPPLEMENT:** Active
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT04301609
- **Lead sponsor:** Vitae Health Innovation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-10
- **Primary completion:** 2022-12-30
- **Final completion:** 2023-01-31
- **Target enrollment:** 67 (ACTUAL)
- **Last updated:** 2023-03-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04301609

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04301609, "Clinical Trial to Assess the Improvement of Fatigue, Sleep Problems, Anxiety / Depression, Neurovegetatives Alterations and Quality of Life After the Administration of ImmunoVita® in Chronic Fatigue Syndrome Patients". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT04301609. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*